GH1 and metabolic dysfunction-associated steatotic liver disease: Chronic replacement of IGF-I did not influence the NAFLD status, again suggesting that GH has a direct action in the liver, particularly for the prevention of steatosis in hepatocytes (Figure 1) [54].